Literature DB >> 6089357

Isolation and characterization of human factor IX cDNA: identification of Taq I polymorphism and regional assignment.

P Jagadeeswaran, D E Lavelle, R Kaul, T Mohandas, S T Warren.   

Abstract

Hemophilia B or Christmas disease is an X-linked condition caused by absent or reduced levels of functional coagulation factor IX. Based upon the peptide sequence of bovine factor IX, we synthesized a 17-base pair oligonucleotide probe to screen a human liver cDNA library. A recombinant clone was identified with a 917-nucleotide insert whose sequence corresponds to 70% of the coding region of human factor IX. This factor IX cDNA was used to probe restriction endonuclease digested human DNA to identify a Taq I polymorphism associated with the genomic factor IX gene as well as to verify that there is a single copy of this gene per haploid genome. The factor IX cDNA was also used to map the locus for factor IX to a region from Xq26 to Xqter. The cloning of human factor IX cDNA and identification of a Taq I polymorphism and its regional localization will provide a means to study the molecular genetics of hemophilia B and permit linkage analysis with nearby loci.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089357     DOI: 10.1007/bf01534851

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  8 in total

1.  Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.

Authors:  B G Schach; S Yoshitake; E W Davie
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  Assignment of the gene for human DNA polymerase alpha to the X chromosome.

Authors:  T S Wang; B E Pearson; H A Suomalainen; T Mohandas; L J Shapiro; J Schröder; D Korn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

3.  Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG.

Authors:  D D Koeberl; C D Bottema; J M Buerstedde; S S Sommer
Journal:  Am J Hum Genet       Date:  1989-09       Impact factor: 11.025

4.  Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX.

Authors:  R A McGraw; L M Davis; C M Noyes; R L Lundblad; H R Roberts; J B Graham; D W Stafford
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Linkage and recombination between fragile X-linked mental retardation and the factor IX gene.

Authors:  S T Warren; T W Glover; R L Davidson; P Jagadeeswaran
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

6.  Population genetics of coagulant factor IX: frequencies of two DNA polymorphisms in five ethnic groups.

Authors:  D B Lubahn; S T Lord; J Bosco; J Kirshtein; O J Jeffries; N Parker; C Levtzow; L M Silverman; J B Graham
Journal:  Am J Hum Genet       Date:  1987-06       Impact factor: 11.025

7.  An integrated approach for identifying and mapping human genes.

Authors:  R Das Gupta; B Morrow; I Marondel; S Parimoo; V L Goei; J Gruen; S Weissman; A Skoultchi; R Kucherlapati
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

8.  Genes for mast-cell serine protease and their molecular evolution.

Authors:  R Huang; L Hellman
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.